Impact of chemokine receptor CX3CR1 in human renal allograft rejection

Transplant Immunology

Volumn 23, Issue 4, 2010, Pages 204-208

  Hoffmann, Ute ^a,b   Bergler, Tobias ^a   Segerer, Stephan ^c   Rümmele, Petra ^d   Krüger, Bernd ^a,e   Banas, Miriam C ^a   Reinhold, Stephan ^a   Banas, Bernhard ^a   Krämer, Bernhard K ^a,e  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b Hospital Barmherzige Bruder Regensburg   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Chemokine receptor; CX3CR1; Dendritic cells; Human renal allograft rejection; Monocytes macrophages

Indexed keywords

AZATHIOPRINE; CD20 ANTIGEN; CD209 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; CYCLOSPORIN A; EVEROLIMUS; FINGOLIMOD; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ACUTE VASCULAR REJECTION; ADULT; ANTIGEN ANTIBODY REACTION; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITIC CELL; DRUG MEGADOSE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY INTERSTITIUM; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; MACROPHAGE; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANTIGENS, CD; BIOLOGICAL MARKERS; DENDRITIC CELLS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOCHEMISTRY; KIDNEY; KIDNEY TRANSPLANTATION; MACROPHAGES; PROGNOSIS; PROTEIN TRANSPORT; RECEPTORS, CHEMOKINE; TREATMENT OUTCOME;

EID: 77956064360     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2010.06.006     Document Type: Article

References (25)

1. Racusen L.C., Solez K., Colvin R.B., Bonsib S.M., Castro M.C., Cavallo T., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999, 55:713-723.
2. el-Sawy T., Fahmy N.M., Fairchild R.L. Chemokines: directing leukocyte infiltration into allografts. Curr Opin Immunol 2002, 14:562-568.
3. Colvin B.L., Thomson A.W. Chemokines, their receptors, and transplant outcome. Transplantation 2002, 74:149-155.
4. Hancock W.W., Wang L., Ye Q., Han R., Lee I. Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. Curr Opin Immunol 2003, 15:479-486.
5. Segerer S., Nelson P.J., Schlondorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000, 11:152-176.
6. Segerer S., Alpers C.E. Chemokines and chemokine receptors in renal pathology. Curr Opin Nephrol Hypertens 2003, 12:243-249.
7. Blaschke S., Koziolek M., Schwarz A., Benohr P., Middel P., Schwarz G., et al. Proinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritis. J Rheumatol 2003, 30:1918-1927.
8. Lavergne E., Combadiere B., Bonduelle O., Iga M., Gao J.L., Maho M., et al. Fractalkine mediates natural killer-dependent antitumor responses in vivo. Cancer Res 2003, 63:7468-7474.
9. Oh D.J., Dursun B., He Z., Lu L., Hoke T.S., Ljubanovic D., et al. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am J Physiol Ren Physiol 2008, 294:F264-F271.
10. Wong B.W., Wong D., McManus B.M. Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease. Cardiovasc Pathol 2002, 11:332-338.
11. Robinson L.A., Nataraj C., Thomas D.W., Howell D.N., Griffiths R., Bautch V., et al. A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol 2000, 165:6067-6072.
12. van L.J., van Oosterhout M.F., Bruggink A.H., van Wichen D.F., van K.J., de K.E., et al. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response. Circulation 2006, 114:1599-1607.
13. Chakravorty S.J., Cockwell P., Girdlestone J., Brooks C.J., Savage C.O. Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesion. Clin Exp Immunol 2002, 129:150-159.
14. Cockwell P., Chakravorty S.J., Girdlestone J., Savage C.O. Fractalkine expression in human renal inflammation. J Pathol 2002, 196:85-90.
15. Segerer S., Hughes E., Hudkins K.L., Mack M., Goodpaster T., Alpers C.E. Expression of the fractalkine receptor (CX3CR1) in human kidney diseases. Kidney Int 2002, 62:488-495.
16. Racusen L.C., Colvin R.B., Solez K., Mihatsch M.J., Halloran P.F., Campbell P.M., et al. Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003, 3:708-714.
17. Hoffmann U., Bergler T., Rihm M., Pace C., Kruger B., Rummele P., et al. Upregulation of TNF receptor type 2 in human and experimental renal allograft rejection. Am J Transplant 2009, 9:675-686.
18. Hoffmann U., Segerer S., Rummele P., Kruger B., Pietrzyk M., Hofstadter F., et al. Expression of the chemokine receptor CXCR3 in human renal allografts-a prospective study. Nephrol Dial Transplant 2006, 21:1373-1381.
19. Damas J.K., Boullier A., Waehre T., Smith C., Sandberg W.J., Green S., et al. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy. Arterioscler Thromb Vasc Biol 2005, 25:2567-2572.
20. Tacke F., Alvarez D., Kaplan T.J., Jakubzick C., Spanbroek R., Llodra J., et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007, 117:185-194.
21. Fogo A.B. Renal fibrosis: not just PAI-1 in the sky. J Clin Invest 2003, 112:326-328.
22. Nankivell B.J., Borrows R.J., Fung C.L., O'Connell P.J., Allen R.D., Chapman J.R. The natural history of chronic allograft nephropathy. N Engl J Med 2003, 349:2326-2333.
23. Granucci F., Foti M., Ricciardi-Castagnoli P. Dendritic cell biology. Adv Immunol 2005, 88:193-233.
24. Ueno T., Tanaka K., Jurewicz M., Murayama T., Guleria I., Fiorina P., et al. Divergent role of donor dendritic cells in rejection versus tolerance of allografts. J Am Soc Nephrol 2009, 20:535-544.
25. Liu P., Yu Y.R., Spencer J.A., Johnson A.E., Vallanat C.T., Fong A.M., et al. CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler Thromb Vasc Biol 2008, 28:243-250.